Annual Cash & Cash Equivalents
$6.81 M
+$5.63 M+478.17%
December 31, 2023
Summary
- As of March 11, 2025, GDTC annual cash & cash equivalents is $6.81 million, with the most recent change of +$5.63 million (+478.17%) on December 31, 2023.
- During the last 3 years, GDTC annual cash & cash equivalents has risen by +$6.14 million (+917.83%).
- GDTC annual cash & cash equivalents is now at all-time high.
Performance
GDTC Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$4.77 M
-$2.04 M-29.97%
June 30, 2024
Summary
- As of March 11, 2025, GDTC quarterly cash and cash equivalents is $4.77 million, with the most recent change of -$2.04 million (-29.97%) on June 30, 2024.
- Over the past year, GDTC quarterly cash and cash equivalents has stayed the same.
- GDTC quarterly cash and cash equivalents is now -38.03% below its all-time high of $7.70 million, reached on June 30, 2023.
Performance
GDTC Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
GDTC Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +478.2% | 0.0% |
| 3 y3 years | +917.8% | 0.0% |
| 5 y5 years | +917.8% | 0.0% |
GDTC Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +478.2% | -38.0% | +346.7% |
| 5 y | 5-year | at high | +917.8% | -38.0% | +346.7% |
| alltime | all time | at high | +917.8% | -38.0% | +346.7% |
CytoMed Therapeutics Limited Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | - | $4.77 M(-30.0%) |
| Dec 2023 | $6.81 M(+478.2%) | $6.81 M(-11.5%) |
| Jun 2023 | - | $7.70 M(+553.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $1.18 M(-36.6%) | $1.18 M(+10.3%) |
| Jun 2022 | - | $1.07 M(-42.5%) |
| Dec 2021 | $1.86 M(+177.7%) | $1.86 M |
| Dec 2020 | $669.10 K | - |
FAQ
- What is CytoMed Therapeutics Limited annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for CytoMed Therapeutics Limited?
- What is CytoMed Therapeutics Limited annual cash & cash equivalents year-on-year change?
- What is CytoMed Therapeutics Limited quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for CytoMed Therapeutics Limited?
- What is CytoMed Therapeutics Limited quarterly cash and cash equivalents year-on-year change?
What is CytoMed Therapeutics Limited annual cash & cash equivalents?
The current annual cash & cash equivalents of GDTC is $6.81 M
What is the all time high annual cash & cash equivalents for CytoMed Therapeutics Limited?
CytoMed Therapeutics Limited all-time high annual cash & cash equivalents is $6.81 M
What is CytoMed Therapeutics Limited annual cash & cash equivalents year-on-year change?
Over the past year, GDTC annual cash & cash equivalents has changed by +$5.63 M (+478.17%)
What is CytoMed Therapeutics Limited quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of GDTC is $4.77 M
What is the all time high quarterly cash and cash equivalents for CytoMed Therapeutics Limited?
CytoMed Therapeutics Limited all-time high quarterly cash and cash equivalents is $7.70 M
What is CytoMed Therapeutics Limited quarterly cash and cash equivalents year-on-year change?
Over the past year, GDTC quarterly cash and cash equivalents has changed by $0.00 (0.00%)